Clinical Trials Browser

Interventional × balixafortide × Plasma cell × Clear all

NCT01413568 2016-02-26

Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01105403 2014-04-23

Exploratory Study on POL6326 in Stem Cell Mobilization

Phase 2 Completed

21 enrolled

Plasma cell

Multiple Myeloma